PHARPharming Group N.V.
11.85USDMkt Cap: 838.72M $P/E: 84.643d ago
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. Th…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap838.72M $
Enterprise Value781.70M $
Revenue (TTM)366.48M $
Gross Profit330.63M $
Net Income (TTM)2.85M $
Revenue/Share5.220 USD
Last Price11.85 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees407
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINNL0010391025
Valuation
P/E (Trailing)84.64
P/E (Forward)38.05
PEG—
EV/EBITDA23.77
EV/Revenue2.13
P/S2.26
P/B3.06
EPS (TTM)0.14
EPS (Forward)0.31
52W Range
11.7350% of range11.97
52W High11.97 USD
52W Low11.73 USD
Profitability
Gross Margin87.90%
Oper. Margin1.46%
EBITDA Margin8.97%
Profit Margin0.76%
ROE1.03%
ROA0.57%
Growth
Revenue Growth-3.20%
Earnings Growth-62.90%
Cash Flow & Leverage
Operating CF54.71M $
CapEx (TTM)755.00K $
FCF Margin10.28%
FCF Yield4.49%
Net Debt-44.99M $
Net Debt/EBITDA-1.37
Balance Sheet
Debt/Equity0.42
Current Ratio3.01
Quick Ratio2.31
Book Value/Sh3.820 USD
Cash/Share2.236 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)34.35 USD
Upside (mean)+189.9%
Target Range23.40 USD – 39.00 USD
$23.40+189.9% to mean$39.00
# Analysts4
Ownership
Shares Out.70.78M
Float69.66M
Insiders0.00%
Institutions0.14%
Short Interest
Short Ratio2.2d
Short % Float0.03%
Short % Out.0.03%
Shares Short19.18K
Short (prev mo.)3.20K
Technical
SMA 5012.62 (-6.1%)
SMA 20015.31 (-22.6%)
Beta0.06
S&P 52W Chg21.00%
Avg Vol (30d)10.88K
Avg Vol (10d)31.08K
Technical Indicators
RSI (14)48.5
MACD-0.2137
MACD Signal-0.3404
MACD Hist.+0.1268
BB Upper13.25 USD
BB Middle11.49 USD
BB Lower9.732 USD
BB Width30.62%
ATR (14)0.6270 USD
Vol Ratio (20d)0.46x